pregnancy & endocrinology-no pics
TRANSCRIPT
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 1/45
Pregnancy & Endocrinology
William HarperHamilton General Hospital
McMaster University
www.drharper.ca
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 2/45
Objectives
Thyroid Disorders & Pregnancy
Normal thyroid phsyiology & pregnancy
Hypothyroidism & pregnancy Thyrotoxicosis & pregnancy
Postpartum thyroid dysfunction
Diabetes & Pregnancy Gestational DM
Type 1 & Type 2 DM & Pregnancy
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 3/45
Case 1
31 year old female
Somalia Canada 3 years ago
G2P1A0, 11 weeks pregnant
Well except fatigue
Hb 108, ferritin 7 (Fe and LT4 interaction?)
TSH 0.2 mU/L, FT4 7 pM Started on LT4 0.05 TSH < 0.01 mU/L
FT4 12 pM, FT3 2.1 pM
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 4/45
Case 1
1. How would you characterize her
hypothyroidism?
2. What are the ramifications of pregnancy to
thyroid function/dysfunction?
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 5/45
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 6/45
TSH
LowHigh
FT4 FT4 & FT3
Low
1° Hypothyroid
Low
Central
Hypothyroid
TRH Stim.
If
equivocal
MRI, etc.
High
1° Thyrotoxicosis
High
2° thyrotoxicosis
•Endo consult
•FT3, rT3
•MRI, α-SU
RAIU
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 7/45
Case 1
GH, IGF-1 normal
LH, FSH, E2, progesterone, PRL normal for
pregnancy
8 AM cortisol 345, short ACTH test normal
MRI: normal pituitary
TGAB, TPOAB negative
Normal pregnancy, delivery, baby, lactation
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 8/45
Thyroid & Pregnancy: Normal Physiology
Increased estrogen increased TBG (peaks wk 15-20) Higher total T4 & T3:
normal FT4 & FT3 if normal thyroid fn. and good assay
many automated FT4 assays underestimate true FT4 level (except
Nichols equilibrium dialysis free T4 assay) if suspect your local FT4 assay is underestimating FT4 can check
total T4 & T3 instead (normal pregnant range ~ 1.5x
nonpregnant)
hCG peak end of 1st trimester, hCG has weak TSH agonist
effect so may cause: slight goitre
mild TSH suppression (0.1-0.4 mU/L) in 9% of preg
mild FT4 rise in 14% of preg
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 9/45
Thyroid & Pregnancy: Normal Physiology
Fetal thyroid starts working at 12-14 wks
T4 & T3 cross placenta but do so minimally
Cross placenta well: MTZ > PTU
TSH-R Ab (stim or block)
ATD (PTU & MTZ): Fetal goitre (can compress trachea after birth)
MTZ aplasia cutis scalp defects
Other MTZ reported embryopathy: choanal atresia, esophagealatresia, tracheo-esophageal fistula
Therefore do NOT use MTZ during pregnancy, use PTU instead
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 10/45
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 11/45
No TSH & FTI at end of 1st trimester
as expected from hCG effect
Requirement to increase LT4 dose
occurred between weeks 4 -20
Despite exponential rise in estradiol
throughout pregnancy (note y-axis
units) TBG levels plateau at 20 wks
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 12/45
• LT4 dose requirement tied to rising TBG levels
(THBI inversely proportional to TBG level)
•By 10 wks need average increase of 29% LT4 dose• By 20 wks need average increase of 48% LT4 dose
• No increase of dose beyond 20 wks required
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 13/45
* Regardless of cause of hypothyroidism (Hashimoto’s,
thyroidectomy) initial LT4 dose increase is usually
required early (~ week 8), before 1st
prenatal visit!
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 14/45
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 15/45
LT4 dose adjustment in Pregnancy:- Optimize TSH preconception (0.4 – 2.5 mU/L)
- TSH at pregnancy diagnosis (~3-4 wk gestation), q1mos during 1st 20
wks and after any LT4 dose change, q2mos 20 wks to term
- Instruct women to take 2 extra thyroid pills/wk (q Mon, Thurs) for 29%dose increase once pregnancy suspected (+ commercial preg test)
- If starting LT4 during preg: initial dose 2 ug/kg/d and recheck TSH q4wk
until euthythyroid
TSH Dose Adjustment
TSH increased but < 10 Increase dose by 50 ug/d
TSH 10-20 Increase dose by 50-75 ug/d
TSH > 20 Increase dose by 100 ug/d
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 16/45
Pregnancy: screen for thyroid dysfn ?
Universal screening not currently recommended: ACOG, AACE, Endo Society, ATA
Controversial!
Definitely screen: Goitre, FHx thyroid dysfn., prior postpartum thyroiditis,
T1DM
Ideally, check TSH preconception: 2.5-5.0 mU/L: recheck TSH during 1st trimester
0.4-2.5 mU/L: do not need to recheck during preg
If TSH not done preconception do at earliestprenatal visit: 0.1-0.4 mU/L: hCG effect (9% preg), recheck in 5wk
< 0.1 mU/L: recheck immediately with FT4, FT3, T4, T3
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 17/45
Thyrotoxicosis & Pregnancy
Causes: Graves’ disease
TMNG, toxic adenoma Thyroiditis
Hydatiform mole
Gestational hCG-asscociated Thyrotoxicosis
• Hyperemesis gravidarum hCG
• 60% TSH, 50% FT4
• Resolves by 20 wks gestation
• Only Rx with ATD if persists > 20 wk
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 18/45
Thyrotoxicosis & Pregnancy
Risks:
Maternal: stillbirth, preterm labor, preeclampsia,
CHF, thyroid storm during labor Fetal: SGA, possibly congenital malformation (if 1st
trimester thyrotoxicosis), fetal tachycardia, hydrops
fetalis, neonatal thyrotoxicosis
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 19/45
Thyrotoxicosis & Pregnancy
Diagnosis difficult: hCG effect:
• Suppressed TSH (9%) +/- FT4 (14%) until 12 wks
• Enhanced if hyperemesis gravidarum: 50-60% withabnormal TSH & FT4, duration to 20 wks
FT4 assays reading falsely low
T4 elevated due to TBG (1.5x normal)
NO RADIOIODINE
Measure: TSH, FT4, FT3, T4, T3, thyroid antibodies?
Examine: goitre? orbitopathy? pretibial myxedema?
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 20/45
Pregnant & Suppressed TSH
TSH < 0.1 TSH 0.1 – 0.4
Recheck in 5 wksFT4, FT3, T4, T3
Thyroid Ab’s
Examine
NormalizesStill suppressed
• Very High TFT’s:
• TSH undetectable
• very high free/total T4/T3
• hyperthyroid symptoms
• no hyperemesis
• TSH-R ab +
• orbitopathy
• goitre, nodule/TMNG
• pretibial myxedema
Treat Hyperthyroidism (PTU)
Hyperemesis Gravidarum
Abnormal TFT’s past 20 wk
Don’t treat with PTU
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 21/45
Thyrotoxicosis & Pregnancy: Rx
No RAI ever (destroy fetal thyroid)
PTU Start 100 mg tid, titrate to lowest possible dose
Monitor qmos on Rx: T4, T3, FT4, FT3
– TSH less useful (lags, hCG suppression)
Aim for high-normal to slightly elevated hormone levels
– T4 150-230 nM, T3 3.8-4.6 nM, FT4 26-32 pM
3rd trimester: titrate PTU down & d/c prior to delivery if TFT’spermit to minimize risk of fetal goitre
Consider fetal U/S wk 28-30 to R/O fetal goitre
If allergy/neutropenia on PTU: 2nd trimesterthyroidectomy
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 22/45
Thyrotoxicosis & Lactation
ATD generally don’t get into breast milk unless at higher doses:
PTU > 450-600 mg/d MTZ > 20 mg/d
Generally safe
I prefer PTU > MTZ for preg lactating
Take ATD dose just after breast-feeding Should provide 3-4h interval before lactates again
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 23/45
Neonatal Grave’s
Rare, 1% infants born to Graves’ moms
2 types:
Transplacental trnsfr of TSH-R ab (IgG) Present at birth, self-limited
Rx PTU, Lugol’s, propanolol, prednisone
Prevention: TSI in mom 2nd trimester, if 5X normal then Rxmom with PTU (crosses placenta to protect fetus) even if momis euthyroid (can give mom LT4 which won’t cross placenta)
Child develops own TSH-R ab Strong family hx of Grave’s
Present @ 3-6 mos
20% mortality, persistant brain dysfunction
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 24/45
Postpartum & Thyroid
5% (3-16%) postpartum women (25% T1DM)
Up to 1 year postpartum (most 1-4 months)
Lymphocytic infiltration (Hashimoto’s)
Postpartum Exacerbation of all autoimmune dx
25-50% persistant hypothyroidism
Small, diffuse, nontender goitre Transiently thyrotoxic Hypothyroid
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 25/45
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 26/45
Postpartum & Thyroid
Distinguish Thyrotoxic phase from Grave’s: No Eye disease, pretibial myxedema
Less severe thyrotoxic, transient (repeat thyroid fn 2-3 mos)
RAI (if not breast-feeding)
Rx: Hyperthyroid symptoms: atenolol 25-50 mg od
Hypothyroid symptoms: LT4 50-100 ug/d to start
• Adjust LT4 dose for symtoms and normalization TSH
• Consider withdrawal at 6-9 months
(25-50% persistent hypothyroid, hi-risk recur future preg)
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 27/45
Postpartum & Thyroid
Postpartum depression When studied, no association between postpartum
depression/thyroiditis
Overlapping symtoms, R/O thyroid before start antidepressents
Screening for Postpartum ThyroiditisHOW: TSH q3mos from 1 mos to 1 year postpartum?
WHO:
– Symptoms of thyroid dysfn.
– Goitre
– T1DM
– Postpartum thyroiditis with prior pregnancy
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 28/45
Objectives
Thyroid Disorders & Pregnancy
Normal thyroid phsyiology & pregnancy
Hypothyroidism & pregnancy Thyrotoxicosis & pregnancy
Postpartum thyroid dysfunction
Diabetes & Pregnancy
Gestational DM
Type 1 & Type 2 DM & Pregnancy
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 29/45
Gestational Diabetes Mellitus (GDM)
“Glucose intolerance with onset/discoveryduring pregnancy”
Some T2DM picked up during pregnancy Rarely some T1DM may present during pregnancy
Prevalence higher than previously thoughtin Canada:
3.5 - 3.8% non-Aboriginal (but multi-ethnic)population
8.0 - 18.0% Aboriginal
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 30/45
Gestational Diabetes Mellitus (GDM)
Prior “selective screening” resulted in missed
cases: Caucassians < 25 y.o.
No personal or FHx of DM
No prior infant with birth weight > 4 kg
Treatment of GDM reduces perinatal morbidity
Diagnosis GDM maternal anxiety ? Evidence controversial for this
Therefore all women should be screened
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 31/45
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 32/45
* Presence of multiple risk factors warrants earlier
screening (preconception, 1st & 2nd trimester)
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 33/45
GDM: Morbidity
Maternal Fetal/NeonatalMacrosomia
(birth trauma,cesarian)
Macrosomia
(shoulder dystocia)
Preeclampsia RDS
Polyhydramnios Neonatal hypoglycemia
Perinatal mortality (fetus) Neonatal hypocalcemia
Postpartum IFG, IGT, DM3-6 mos: 16-20 %
Lifetime: 30-50 %
Neonatal jaundice
Obesity later in life?
IGT, IFG, or DM later in life?
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 34/45
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 35/45
GDM Treatment
CBG qid: FBS, 1-2h pc Dietary: 3 small meals, 3 small snacks
If glycemic targets not met: Insulin
Multiple Daily Injection (MDI) best
Insulins: regular, lispro, aspart ? (still new)
No glargine (stimulates IGF-I receptors)
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 36/45
GDM Treatment
No OHA’s, not standard of care yet.
Glyburide
Minimal crossing of placenta, 3rd
trimester most organogenesiscomplete
1 RCT: 404 women, mild GDM, glyburide vs. insulin, no
difference in outcomes
Further study before safety established
Metformin Retrospective cohort:
• preeclampsia & stillbirth
• Bias: DM women older, more obese
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 37/45
GDM: Labour & Postpartum
NPO during Labour: Monitor CBG q1h, target BS 4 – 6.5 mM
Hypoglycemia (BS < 4 mM): IV D5W
Hyperglycemia (BS > 6.5 mM): IV D5W & IV insulin gtt
Postpartum: D/C all insulin (IV and SC)
CBG in recovery:
• > 10 mM CBG qid, may need Rx for T2DM
• < 10 mM stop CBG monitoring
FBS or 2hPG in 75g OGTT within 6 mos postpartum and prior to anyfuture planned pregnancies
Encourage: breast feeding, healthy diet, exercise to prevent futureType 2 DM, GDM
Screen for future T2DM (GDM is a risk factor)
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 38/45
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 39/45
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 40/45
T1DM, T2DM & Pregnancy Congenital anomalies: 2-3x increased risk
Cardiac malformations
Neural Tube Defects 1 % risk
Folate 1-4 mg/d (Prenatal vitamin 0.4-1.0 mg)
d/c ACE-I and ARBs methyldopa, etc.
Dilated eye exam: preconception & 1st trimester
T2DM: d/c OHA insulin
Good glycemic control prior to conception: Prevent unplanned pregnancies: OCP or 2x barrier
Initiate MDI and qid (FBS, 2hPC) prior to preg
CSII also another option
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 41/45
T1DM, T2DM & Pregnancy
< 8.0 ?
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 42/45
T1DM & T2DM: Labour & Postpartum
NPO during Labor: Monitor CBG q1h, target BS 4.0 – 6.5 mM
IV D5W & IV insulin gtt (Hamilton Health Sciences Protocol)
Postpartum: D/C all IV insulin
Insulin resistance/requirements rapidly fall during & after labor
T2DM: monitor CBG qid
• Restart insulin if CBG > 10 mM
T1DM: postpartum honeymoon
• CBG q1h x 4h, then q2h x 4h, then q4h
• Restart MDI insulin S.C. when CBG > 10 mM
No OHA, ACE-I or ARB during breast feeding!
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 43/45
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 44/45
7/29/2019 Pregnancy & Endocrinology-No Pics
http://slidepdf.com/reader/full/pregnancy-endocrinology-no-pics 45/45
END